News | News By Subject | News by Disease News By Date | Search News

Leukemia News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novartis AG (NVS) Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug     3/30/2017
Bernie Sanders Demands Info on Ariad (ARIA)'s Leukemia Drug     10/24/2016
FDA Berates Celator Pharma (CPXX) for Pushing Unapproved Leukemia Drug to Doctors     9/8/2016
KaloBios (KBIO) Fires Martin Shkreli, UC Davis Suspends Leukemia Trial Due to Shkreli     12/23/2015
Poland’s Selvita Stakes Out its Own Space in U.S. Pharma Hubs of Boston and San Francisco     9/18/2015
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
Step Aside Juno (JUNO): World's Richest Doctor Pulls Off Largest Biotech IPO Ever     8/4/2015
FDA OKs Juno (JUNO)'s IND for Lead Leukemia Candidate JCAR015     8/3/2015
Amgen (AMGN) Lauds Positive Phase II Data for Leukemia Drug Blincyto     7/17/2015
Baxter International (BAX) Puts Down $900 Million to Beef Up Cancer Products for Spinoff     5/13/2015
AbbVie (ABBV), Genentech (RHHBY) Leukemia Drug Wins Breakthrough Status Tag     5/11/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
AbbVie (ABBV) Overpaid in Pharmacyclics (PCYC) Deal, For Only 50% Rights to Imbruvica: Analyst     3/6/2015
EXCLUSIVE: Experimental Cancer Drug From Oncoceutics Could Be Fast-Tracked, Says Exec     3/6/2015
Eagle Pharmaceuticals (EGRX), Teva Pharmaceutical Industries (TEVA) Forge $120 Million Leukemia Drug Pact     2/18/2015

News from Around the Web
2 Babies With Leukemia Are In Remission More Than A Year After Getting Treated With Gene-Edited Cells     1/27/2017
A New Antibody For Treating Acute Lymphocytic Leukemia?     12/6/2016
Small-Molecule Tool Could Reduce Leukemia Cell Regeneration, University of California, San Diego (UCSD) Study     6/13/2016
Body's Own Gene Editing System Generates Leukemia Stem Cells, University of California San Diego School of Medicine Study Reveals     6/10/2016
Untested ‘Designer Cell’ Treatment Saved One Year Old From Leukemia, Great Ormond Street Hospital Reveals     4/11/2016
Main Ingredient Of Artificial Sweetener Splenda Linked To Leukemia, Study Published In International Journal Of Occupational And Environmental Health     3/14/2016
Umbilical Blood Cells Kill Cancer Quicker Than Adult Cells, Great Ormond Street Hospital For Children Study     2/8/2016
New Way For Early Detection Of Potentially Deadly Fungal Infection In Leukemia Patients Discovered, University of Texas Medical Branch at Galveston Researchers Reveal     12/15/2015
Designer Cells Cure One-Year Old Cancer Patient, Nature Reveals     11/6/2015
Avocados May Help Fight Blood Cancer, University Of Waterloo Study     6/17/2015
How Red Wine Prevents Cancer, University of Colorado Study     12/5/2014
New Drug May Be Effective Against Many Cancer Types, University College London Study     6/13/2014
Drugs To Watch: Potential Blockbusters Of 2014     4/17/2014
Mutations In Leukemia Gene Linked To New Childhood Growth Disorder, The Institute of Cancer Research Study     3/10/2014
Discovery of Novel Gene Mutations in Leukemia Patients Opens Up Personalized Therapy Options, Ludwig-Maximilians-University and Helmholtz Zentrum Munchen Study     8/5/2013

Press Releases
Pfizer (PFE) Receives Positive CHMP Opinion For BESPONS (Inotuzumab Ozogamicin) For The Treatment Of Relapsed Or Refractory Acute Lymphoblastic Leukemia     4/24/2017
Pfizer (PFE) Receives Positive CHMP Opinion For BESPONSA (Inotuzumab Ozogamicin) For The Treatment Of Relapsed Or Refractory Acute Lymphoblastic Leukemia     4/21/2017
City of Hope Researchers Successfully Prevent Graft-Versus-Host Disease While Preserving Strong Graft Versus Leukemia Effects In Preclinical Study     4/18/2017
Cyclacel Pharma (CYCC) Presents Identification Of Sensitive Target Indications And Synergistic Drug Combinations For Novel PLK1 Inhibitor CYC140     4/5/2017
Jazz Pharma (JAZZ) Completes Rolling Submission Of New Drug Application For Vyxeos (CPX-351), An Investigational Treatment For Acute Myeloid Leukemia     4/3/2017
Panacea Pharmaceuticals, Inc. Presents Data On Targeted Killing Of Leukemia Cells By Its Radiolabeled Monoclonal Antibody To The Cancer Biomarker HAAH     3/30/2017
QIAGEN N.V. (QGEN) Launches First FDA-Cleared JAK2 Test For Certain Type Of Leukemia     3/30/2017
Cyteir Therapeutics Presents Preclinical Data Validating RAD51-AID As A Novel Target For Cancer Treatment At AACR Annual Meeting     3/28/2017
Moleculin Biotech (MBRX) Receives Orphan Drug Designation For Annamycin For The Treatment Of Acute Myeloid Leukemia     3/22/2017
Cincinnati Children's Hospital Medical Center Release: Scientists Find Possible Achilles Heel Of Treatment Resistant Cancers     3/21/2017
Servier And Pfizer (PFE) Announce FDA Clearance Of IND Application For UCART19 In Adult Relapsed/Refractory Acute Lymphoblastic Leukemia     3/9/2017
The OHSU Knight Cancer Institute Release: "The New England Journal of Medicine" Publishes Long-Term Results Of Gleevec® For Patients With Chronic Myeloid Leukemia     3/9/2017
Munich Leukemia Laboratory Selects IBM Watson Health And Illumina (ILMN) For Research Collaboration To Advance Diagnostics And Develop Personalized Treatment Tools For Leukemia & Lymphoma     3/8/2017
Amgen (AMGN) Release: BLINCYTO (blinatumomab) Significantly Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia Compared To Chemotherapy     3/2/2017
Celgene (CELG) Release: FDA Accepts New Drug Application And Grants Priority Review For Enasidenib In Relapsed Or Refractory AML With An IDH2 Mutation     3/1/2017

//-->